Erie County Medical Center, Corp

Buffalo, New York 14215

0 studies enrolling now · 3 studies all time

What they study most

Antibody-mediated Rejection, Schizophrenia

Studies at this site

• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early
• A Twelve Week, Open Label Extension Study in Patients With Schizophrenia — Completed
• Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia — Completed